NCODA International Executive Council to Advance Medically Integrated Oncology Worldwide

NCODA

PR99716

 

CAZENOVIA, N.Y., March 10, 2023 /PRNewswire=KYODO JBN/ --

 

NCODA (

https://c212.net/c/link/?t=0&l=en&o=3800098-1&h=2079229491&u=https%3A%2F%2Fwww.ncoda.org%2F&a=NCODA

) a non-profit organization whose Mission is to empower the

medically-integrated oncology team to deliver positive, patient-centered

outcomes is proud to announce the formation of its International Executive

Council (IEC). The IEC will provide insight and leadership to NCODA regarding

meeting the ever-changing needs of oncology patients and healthcare

professionals around the world.

 

Logo - https://mma.prnewswire.com/media/1765941/NCODA_Logo.jpg

 

NCODA is a leading non-profit organization (NY, USA) dedicated to improving the

quality of cancer care and promoting the highest standards in the field of

oncology practice.

 

The formation of the IEC is a significant step in NCODA's Mission to improve

cancer care on a global scale. The council includes leaders from diverse

regions of the world. These leaders will share their unique perspectives and

collaborate on global initiatives.

 

"The IEC will provide a forum for international collaboration and knowledge

sharing, enabling us to learn from each other and work together to improve the

care of cancer patients worldwide," said Michael Reff, RPh, MBA, Founder and

Executive Director of NCODA.

 

The IEC is Chaired by Dr. Marko Skelin, MPharm, PhD, Deputy Director of General

Hospital Sibenik in Zagreb, Croatia. Dr. Skelin, along with NCODA executive

leadership, will oversee the council's activities, including the development of

global educational resources, the promotion of best practices, and the

implementation of global initiatives to improve cancer care.

 

"Global collaboration in cancer care is crucial to decrease inequities in

cancer care between different countries in order to improve the outcomes that

are truly important to our patients, such as survival and quality of life,"

said Skelin, MPharm, PhD.

 

International Executive Council members include (view bios

https://c212.net/c/link/?t=0&l=en&o=3800098-1&h=2731640332&u=https%3A%2F%2Fwww.ncoda.org%2Fncoda-international-executive-council-to-advance-medically-integrated-oncology-worldwide%2F&a=view+bios

):

 

    -- Marko Skelin, MPharm, PhD (Chair), Croatia

    -- Shreya Badhrinarayanan, MD, FRSHP, United States

    -- Khalid El Bairi, MD, Morocco

    -- Steven Bloom, BPharm, United States & France

    -- Natasha Khrystolubova, RPh, BCOP, United States

    -- Christine Lariviere, BPharm, Canada

    -- Victor Lisboa, MD, Brazil

    -- Kashyap Patel, MD, United States

    -- George Patrinos, PhD, Greece

    -- Elzbieta Senkus-Konefka, MD, PhD, Poland

    -- Shinya Suzuki, MS, PhD, JOP, Japan

    -- Martin Whalen, MBA, Sweden

 

The launch of the IEC marks a significant milestone in NCODA's commitment to

advancing the practice of oncology pharmacy and improving cancer care worldwide.

 

For more information about NCODA and the International Executive Council,

please visit www.ncoda.org.

 

Media Contact:

Name: Katie Edmiston

Email: Katie.Edmiston@ncoda.org

 

SOURCE  NCODA

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

SNSでも最新のプレスリリース情報をいち早く配信中